Dr. Jose A. Aguirre, MD

Dr. Aguirre practices at Mountain View Health and Rehabilitation - Carson City in Carson City, Nevada.

Dr. Aguirre's NPI, 1295785566, was assigned on May 10, 2006. Dr. Aguirre holds Florida license ME148377.

Dr. Aguirre's primary practice is Mountain View Health and Rehabilitation - Carson City, at 201 Koontz Lane, Carson City, NV 89701 in Carson City. The practice phone is (775) 883-3622.

Dr. Aguirre's primary practice is Mountain View Health and Rehabilitation - Carson City in Carson City, Nevada. Dr. Aguirre is also affiliated with Saint Mary's Regional Medical Center. The medical group on file is Benson Hospital. Dmand AI also links Dr. Aguirre to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aguirre practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Aguirre's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Aguirre's licenses on file in 9 states: Florida, California, Colorado, Maryland, Montana, New Mexico, Nevada, New York and Tennessee.

CMS data shows 17 Medicare services from Dr. Aguirre across 1 procedure code in 2024, for 33 Medicare patients. Medicare paid $1,473 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Aguirre in 2024. The largest group is 75 to 84, with 12 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aguirre's median patient age at 73, with 61% women.

In 2024, Dr. Aguirre wrote 795 Medicare Part D claims for 168 patients. 88% of them were for generic drugs. CMS names the drug for 406 of them, across 20 drugs with 11 or more claims each, at $3,742 in total drug cost. In 2023, CMS named 380 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 49 out of 100 for Dr. Aguirre for performance year 2024, reported as part of a group. Dr. Aguirre accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 41 general payments to Dr. Aguirre from 9 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 92% of the total. Boston Scientific Corporation paid the most, $530.